Cargando…
A Systematic Review of Side Effects of Nucleoside and Nucleotide Drugs Used for Treatment of Chronic Hepatitis B
Although nucleosides and nucleotides have a good safety record for the treatment of hepatitis B, there have been no systematic reviews on this topic. We searched Medline to include studies of the oral antiviral agents for hepatitis B and adverse events, with at least 48 weeks of follow-up from the i...
Autores principales: | Khungar, Vandana, Han, Steven-Huy |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861763/ https://www.ncbi.nlm.nih.gov/pubmed/20461127 http://dx.doi.org/10.1007/s11901-010-0039-1 |
Ejemplares similares
-
Adherence to Nucleoside/Nucleotide Analogue Treatment in Patients with Chronic Hepatitis B
por: Tütüncü, Emin Ediz, et al.
Publicado: (2017) -
Adherence to Treatment with Oral Nucleoside/Nucleotide Analogs in Patients with Chronic Hepatitis B
por: Ozyigitoglu, Derya, et al.
Publicado: (2022) -
Profile of hepatitis B virus resistance mutations against nucleoside/nucleotide analogue treatment in Chinese patients with chronic hepatitis B
por: Lei, Jun, et al.
Publicado: (2013) -
Fanconi’s Syndrome and Dementia in a Patient With Chronic Hepatitis B Taking Nucleoside/ Nucleotide Analogue
por: Ho, Cheuk Wah, et al.
Publicado: (2021) -
Air pollution impede ALT normalization in chronic hepatitis B patients treated with nucleotide/nucleoside analogues
por: Jang, Tyng-Yuan, et al.
Publicado: (2023)